FDA launches new market pathway for breakthrough medical devices

By Stewart Eisenhart, Emergo Group

The US Food and Drug Administration plans to establish a new market authorization pathway for innovative and breakthrough medical devices that would replace current priority review programs including the Expedited Access Pathway (EAP) and the Priority Review Program.

Get the full story here at the Emergo Group’s blog.

The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.

The post FDA launches new market pathway for breakthrough medical devices appeared first on MassDevice.

from MassDevice http://ift.tt/2xEl9pf